20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
BioXcel Therapeutics (NASDAQ:BTAI) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
BioXcel Therapeutics missed estimated earnings by 10.66%, reporting an EPS of $-1.35 versus an estimate of $-1.22.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03 which was followed by a 1.14% drop in the share price the next day.
To track all earnings releases for BioXcel Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!